Neovacs Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.57	0.44	0.89	0.04	16.25
Short-Term Investments	0	0	0	6.72	16.84
Cash & Short-Term Investments	0.57	0.44	0.89	6.76	33.09
Cash Growth	31.31%	-50.91%	-86.87%	-79.57%	228.45%
Accounts Receivable	0.41	0.31	0.57	0.01	0.01
Other Receivables	1.55	1.65	2.21	1.8	1.59
Total Trade Receivables	1.95	1.95	2.78	1.81	1.6
Other Current Assets	0.14	0.12	0.17	0.53	0.09
Total Current Assets	2.63	2.46	3.84	9.1	34.78
Net Property, Plant & Equipment	0.24	0.41	0.53	0.51	0.51
Other Intangible Assets	0	0	0	0	0
Long-Term Investments	18.64	18.68	41.49	42.33	13.2
Other Long-Term Assets	0.62	0.47	6.71	3.36	0.07
Total Assets	22.17	22.07	52.56	55.29	48.55
Accounts Payable	1.87	2.28	1.98	1.93	1.32
Accrued Expenses	0.71	1.29	0.98	1.4	0.83
Other Current Liabilities	0.03	0.05	0.1	0.12	0.15
Total Current Liabilities	2.61	3.61	3.06	3.45	2.29
Long-Term Debt	0.54	0.23	0.65	1.2	1.03
Other Long-Term Liabilities	0.96	0.17	0.01	0.47	1.32
Total Long-Term Liabilities	1.5	0.4	0.66	1.68	2.36
Total Liabilities	3.15	3.84	3.71	5.12	4.65
Common Stock	0.19	0.17	0.35	0.12	1.99
Additional Paid-in Capital	79.44	77.57	141.78	139.67	135.12
Retained Earnings	-61.57	-60.34	-94.6	-89.63	-93.22
Total Common Shareholders' Equity	18.06	17.41	47.53	50.17	43.9
Minority Interest	-	0.65	1.31	0	-
Shareholders' Equity	18.06	17.41	48.84	50.17	43.9
Total Liabilities & Equity	22.17	22.07	52.56	55.29	48.55
Total Debt	0.54	0.23	0.65	1.2	1.03
Net Cash (Debt)	0.03	0.21	0.24	5.55	32.06
Net Cash Growth	-83.31%	-13.29%	-95.74%	-82.67%	231.12%
Net Cash Per Share	-	-	0.67	82.27	474.76
Book Value	18.06	17.41	47.53	50.17	43.9
Book Value Per Share	-	-	135.15	742.99	650.19
Tangible Book Value	18.06	17.41	47.53	50.16	43.9
Tangible Book Value Per Share	-	-	135.15	742.95	650.17